Author

Hyun-Soo Kim

EFFECTIVENESS OF ERGONOMICS PROGRAM BASED ON MOVEMENT ANALYSIS FOR EXPERIENCED ENDOSCOPISTS: A PILOT STUDY
EFFECTIVENESS OF ERGONOMICS PROGRAM BASED ON MOVEMENT ANALYSIS FOR EXPERIENCED ENDOSCOPISTS: A PILOT STUDY

Hyun-Soo Kim  et al.

RISKOF CERVICAL CANCER IN INCIDENT ULCERATIVE COLITIS: A NATIONWIDE POPULATION-BASED STUDY SPANNING 10 YEARS
RISKOF CERVICAL CANCER IN INCIDENT ULCERATIVE COLITIS: A NATIONWIDE POPULATION-BASED STUDY SPANNING 10 YEARS

Hyun-Soo Kim  et al.

RISKOF CERVICAL CANCER IN INCIDENT ULCERATIVE COLITIS: A NATIONWIDE POPULATION-BASED STUDY SPANNING 10 YEARS
RISKOF CERVICAL CANCER IN INCIDENT ULCERATIVE COLITIS: A NATIONWIDE POPULATION-BASED STUDY SPANNING 10 YEARS

HIGH C-REACTIVE PROTEIN LEVEL OF ACUTE SEVERE ULCERATIVE COLITIS IS ASSOCIATED WITH RE-ADMISSION DUE TO AGGRAVATION OF ULCERATIVE COLITIS: A KASID MULTICENTER STUDY
HIGH C-REACTIVE PROTEIN LEVEL OF ACUTE SEVERE ULCERATIVE COLITIS IS ASSOCIATED WITH RE-ADMISSION DUE TO AGGRAVATION OF ULCERATIVE COLITIS: A KASID MULTICENTER STUDY

Hyun-Soo Kim  et al.

RANDOMISED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ZASTAPRAZAN COMPARED WITH ESOMEPRAZOLE IN EROSIVE OESOPHAGITIS [ZASTAPRAZAN EROSIVE REFLUX OESOPHAGITIS-1 STUDY (ZERO-1)]
RANDOMISED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ZASTAPRAZAN COMPARED WITH ESOMEPRAZOLE IN EROSIVE OESOPHAGITIS [ZASTAPRAZAN EROSIVE REFLUX OESOPHAGITIS-1 STUDY (ZERO-1)]

Hyun-Soo Kim  et al.

ENDOSCOPIC ULTRASONOGRAPHIC FINDINGS OF SUBEPITHELIAL LESION IN THE UPPER GASTROINTESTINAL TRACT WITH AN INCREASE IN SIZE
ENDOSCOPIC ULTRASONOGRAPHIC FINDINGS OF SUBEPITHELIAL LESION IN THE UPPER GASTROINTESTINAL TRACT WITH AN INCREASE IN SIZE

Hyun-Soo Kim  et al.

RANDOMISED CLINICAL TRIAL: COMPARISON OF TEGOPRAZAN AND LANSOPRAZOLE FOR THE MAINTENANCE THERAPY IN HEALED EROSIVE ESOPHAGITIS
RANDOMISED CLINICAL TRIAL: COMPARISON OF TEGOPRAZAN AND LANSOPRAZOLE FOR THE MAINTENANCE THERAPY IN HEALED EROSIVE ESOPHAGITIS

Hyun-Soo Kim  et al.

ETROLIZUMAB VERSUS INFLIXIMAB FOR TREATING PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 GARDENIA STUDY
ETROLIZUMAB VERSUS INFLIXIMAB FOR TREATING PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 GARDENIA STUDY

Hyun-Soo Kim  et al.

Item 1 - 8 / 8
1